Trestolone

Trestolone was developed to shut down testosterone production

Trestolone, or MENT (7-alpha-methyl-19-nortestosterone), was investigated as a male hormonal contraceptive. The intended mechanism was complete suppression of the natural axis while supplying enough androgen to maintain function. This section holds 6 lines from £55 to £170, averaging near £105.

Total suppression is not an unfortunate side effect here. It is the design specification.

What that means practically

Every compound in this catalogue suppresses to some degree. Trestolone was selected and developed because it suppresses completely and reliably at low doses — that was the endpoint the research was optimising for.

Anyone treating recovery as a manageable afterthought has misread what they are taking. Post cycle therapy after trestolone is a more serious proposition than after most compounds, and it should be planned before the first injection rather than after.

Potency

It is extremely potent by weight — considerably more so than testosterone in the assays used to characterise it. That potency is real and it is also why dosing errors matter more here than with milder compounds.

The oestrogen issue

Trestolone aromatises, and it converts to a potent oestrogen rather than a weak one. Oestrogenic effects can therefore appear quickly and at doses that would be unremarkable elsewhere, so oestrogen control is more likely to be needed rather than less.

Being 19-nor derived, it also carries progestogenic activity of the kind seen with nandrolone — a separate pathway that aromatase inhibitors do not address.

What is not known

It never reached approval, so there is no long-term safety data in the physique context. What exists is contraceptive research at contraceptive doses, which is a narrower evidence base than its potency warrants. Supplier verification is in how to check a brand is genuine.

Why it attracts interest despite all that

Because it works, and visibly. Reports describe rapid gains at low doses, which is what a compound with this potency profile would be expected to produce. The appeal is real and so is everything above it on this page.

Where it sits in the catalogue

It is among the more specialised items stocked and belongs in the same mental category as the harsher compounds in the injectable range rather than alongside anything described as mild. It is not a compound to try in order to see what happens.

Frequently asked questions

Why was trestolone developed?
As a male hormonal contraceptive. Complete suppression of natural production was the goal.

How suppressive is it?
Total, at low doses. That was the design specification rather than a side effect.

Does it aromatise?
Yes, into a potent oestrogen, so oestrogenic effects can appear quickly.

Is it progestogenic?
It is 19-nor derived, so yes — a separate pathway from oestrogen and not addressed by aromatase inhibitors.

Is there long-term safety data?
Not for physique use. The research is contraceptive work at contraceptive doses.